Divergent Q4 Earnings: Avanos Medical Outperforms as American Tower Faces Churn
Avanos Medical (AVNS) reported a strong 2025 finish with sales exceeding revised targets, driven by its Specialty Nutrition Systems segment. In contrast, American Tower (AMT) faces a challenging 2026 outlook due to a payment default by DISH and increased international churn.